Sam Hopkins
About Sam Hopkins
Sam Hopkins is a Principal Scientist at Asklepios BioPharmaceutical, Inc., where he leads the development of AAV derived vectors for Pompe Disease. He has extensive experience in the biopharmaceutical industry, having held senior positions at various companies, including Scynexis and Trimeris.
Work at Asklepios BioPharmaceutical
Sam Hopkins has been serving as Principal Scientist at Asklepios BioPharmaceutical, Inc. (AskBio) since 2018. In this role, he leads the development of AAV derived vectors specifically for the treatment of Pompe Disease. He plays a key role in establishing the company infrastructure for clinical sciences and is responsible for designing and supervising clinical studies in patients with Late Onset Pompe Disease (LOPD) and Infantile Onset Pompe Disease (IOPD). Additionally, he manages collaborative research with external investigators and communicates with the investment community and pharmaceutical collaborators.
Previous Experience at Scynexis
Prior to his current position, Sam Hopkins worked at Scynexis as Chief Scientific Officer from 2006 to 2012. His tenure at Scynexis lasted six years and took place in Research Triangle Park, North Carolina. In this role, he contributed to the company's scientific direction and strategic initiatives.
Career at Trimeris
Sam Hopkins held multiple positions at Trimeris between 1995 and 2001. He served as Director of Drug Development from 1995 to 1997, followed by Vice President of Medical Affairs from 1997 to 1999. He later became Senior Vice President of Medical Affairs and then Senior Vice President of Exploratory Development until 2001. His work at Trimeris focused on drug development and medical affairs, contributing to the company's research initiatives.
Education and Expertise
Sam Hopkins earned a Doctor of Philosophy (Ph.D.) in Biochemistry, Biophysics, and Molecular Biology from Virginia Commonwealth University, where he studied from 1980 to 1985. He also holds a Bachelor of Arts (B.A.) in Biology from Western Maryland College, where he studied from 1978 to 1980. His academic background provides a strong foundation for his expertise in biopharmaceutical research and development.
Leadership at Parion Sciences
From 2001 to 2006, Sam Hopkins served as President of Research and Development at Parion Sciences. His leadership in this role contributed to the advancement of the company's research objectives and development strategies, further solidifying his expertise in the biopharmaceutical industry.